Synergy Spine Solutions Names Troy Wahlenmaier Chief Commercial Officer

Synergy Spine Solutions has appointed Troy Wahlenmaier as Chief Commercial Officer, tasking him with leading the company’s global sales and marketing efforts as it advances toward U.S. commercialization of its artificial cervical disc replacement technology.

Wahlenmaier brings over three decades of commercial leadership in the medical device sector, including 13 years at SI-BONE, where he served as Senior Vice President of U.S. Sales. Under his leadership, SI-BONE achieved an average annual U.S. revenue growth of 20%, with projections reaching $188 million in 2025. He built and managed a commercial organization of more than 200 team members and a distributor network, contributing to the company’s first quarter of positive adjusted EBITDA and cash flow breakeven.

His career also includes leadership roles at NuVasive, Kyphon, SpineTech, and United States Surgical Corporation, consistently surpassing revenue targets and guiding teams through early-stage commercialization, market expansion, and operational execution.

CEO Josh Butters described Wahlenmaier as a “visionary leader” with the ability to create scalable, culture-driven teams. Wahlenmaier said he was drawn to Synergy’s focus on innovation and patient outcomes, adding that he looks forward to strengthening the company’s market presence and delivering sustained value to stakeholders.